His primary scientific interests are in Surgery, Internal medicine, Haemophilia, Pediatrics and Intensive care medicine. His Surgery study incorporates themes from Immunosuppression, Fibrinogen and Fresh frozen plasma. His Internal medicine course of study focuses on Gastroenterology and Adverse effect.
The Haemophilia study combines topics in areas such as Coagulopathy, Regimen, Factor IX, Guideline and Family medicine. He studied Pediatrics and Incidence that intersect with Hemophilias, Cohort, Cohort study, Severe hemophilia A and Interquartile range. His Intensive care medicine research is multidisciplinary, incorporating elements of Pregnancy, Afibrinogenemia, Disease, Coagulation Disorder and Recombinant factor VIIa.
His main research concerns Internal medicine, Surgery, Haemophilia, Pediatrics and Platelet. His biological study deals with issues like Endocrinology, which deal with fields such as Immunology. His Surgery research focuses on Fresh frozen plasma and how it connects with Blood transfusion.
The study incorporates disciplines such as Guideline and Cohort in addition to Haemophilia. His Pediatrics research is multidisciplinary, relying on both Prospective cohort study, Incidence and Acquired haemophilia. His Platelet research includes themes of Biochemistry and Coagulation.
Internal medicine, Haemophilia, Platelet, Surgery and Pediatrics are his primary areas of study. Peter Collins has included themes like Gastroenterology and Endocrinology in his Internal medicine study. His work deals with themes such as Physical therapy, Interquartile range and Severity of illness, which intersect with Haemophilia.
His work on Platelet activation as part of his general Platelet study is frequently connected to Scott syndrome, thereby bridging the divide between different branches of science. His research in Surgery intersects with topics in Placebo, Adverse effect and Intensive care medicine. The various areas that Peter Collins examines in his Pediatrics study include Treatment outcome and Bruise.
His scientific interests lie mostly in Surgery, Internal medicine, Platelet, Intensive care medicine and Blood transfusion. His research integrates issues of Pharmacokinetics, Gastroenterology, Factor IX, Adverse effect and Placebo in his study of Surgery. Many of his studies on Internal medicine apply to Guideline as well.
Peter Collins interconnects Anesthesia, Fibrinogen and Cell biology in the investigation of issues within Platelet. Peter Collins combines subjects such as Haemophilia and Bleeding episodes with his study of Intensive care medicine. His Blood transfusion research incorporates elements of Coagulopathy, Organ dysfunction and Obstetrics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.
Peter W. Collins;Sybil Hirsch;Trevor P. Baglin;Gerard Dolan.
The rare coagulation disorders – review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation
P. H. B. Bolton-Maggs;D. J. Perry;E. A. Chalmers;L. A. Parapia.
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Angela Huth-Kühne;Francesco Baudo;Peter Collins;Jørgen Ingerslev.
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
P. Knoebl;P. Marco;F. Baudo;Peter William Collins.
Journal of Thrombosis and Haemostasis (2012)
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study
S. E. Antonarakis;J. P. Rossiter;M. Young;J. Horst.
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
Charles R. M. Hay;S. Brown;Peter William Collins;D. M. Keeling.
British Journal of Haematology (2006)
Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.
Pratima Chowdhury;Anton G. Saayman;Ulrike Paulus;George P. Findlay.
British Journal of Haematology (2004)
Testosterone Induces Dilation of Canine Coronary Conductance and Resistance Arteries In Vivo
Tony M. Chou;Krishnankutty Sudhir;Stuart J. Hutchison;Eitetsu Ko.
A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO
Paula H. B. Bolton-Maggs;Elizabeth A. Chalmers;Peter W. Collins;Paul Harrison.
British Journal of Haematology (2006)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.
Tim Meyer;Tim Meyer;Richard Fox;Yuk Ting Ma;Paul J Ross;Paul J Ross.
The Lancet Gastroenterology & Hepatology (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: